Expression of microRNA‑21 in osteoporotic patients and its involvement in the regulation of osteogenic differentiation

Zhao,Zhongfu; Li,Xiaoguang; Zou,Dexun; Lian,Yongyun; Tian,Shaohua; Dou,Zhi

doi:10.3892/etm.2018.6998

Expression of microRNA‑21 in osteoporotic patients and its involvement in the regulation of osteogenic differentiation

Authors:
- Zhongfu Zhao
- Xiaoguang Li
- Dexun Zou
- Yongyun Lian
- Shaohua Tian
- Zhi Dou
View Affiliations

Affiliations: Department of Orthopaedic Surgery, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang 161006, P.R. China, Department of Orthopaedics, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Orthopaedics, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang 161000, P.R. China, Department of Orthopaedics (Ⅱ), The First Hospital of Qiqihar City, Qiqihar, Heilongjiang 161005, P.R. China
Published online on: November 21, 2018 https://doi.org/10.3892/etm.2018.6998
Pages: 709-714
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Expression of microRNA‑21 in bone tissue and serum of patients with osteoporosis (OP) and its involvement in the regulation of osteogenic differentiation of rat bone marrow mesenchymal stem cells (BMSCs) were investigated. Bone tissue and serum were collected from 48 patients with OP and 48 normal subjects. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) was used to detect the expression of six microRNAs. Among these microRNAs, the expression level of microRNA‑21 in bone tissue and serum of OP patients was the lowest. In addition, BMSCs of SD rats were isolated and cultured. Subculture was performed 3 times, transfection of microRNA‑21 was performed and osteogenic differentiation was induced. Control group [negative control (NC)] was transfected with microRNA‑21 mimics followed by osteogenic induction. Experimental groups were transfected with microRNA‑21 analogue (mimics) and microRNA‑21 inhibitor (inhibitor) followed by osteogenic induction. Ten days after osteogenic induction, alkaline phosphatase (ALP) staining and alizarin red staining were performed to measure the mineralized stained area and the number of mineralized nodules in each treatment group. RT‑qPCR was used to detect the expression of osteogenic genes in each group of cells. RT‑qPCR results showed that microRNA‑21 expression was lower in bone tissue and serum of patients with OP than that of normal subjects. Moreover, compared with control group, BMSCs showed increased stained mineralized areas, deeper color and increased number of mineralized nodules. In addition, increased mRNA expression of osteogenic genes was evident after microRNA‑21 mimics transfection and osteogenic induction (p<0.05). Compared with control group, BMSCs showed decreased stained mineralized areas, lighter color, decreased number of mineralized nodules, and decreased mRNA expression of osteogenic genes after microRNA‑21 inhibitor transfection and osteogenic induction (p<0.05). MicroRNA‑21 is expressed at low level in bone tissue and serum in patients with OP, and microRNA‑21 can promote osteogenic differentiation of BMSCs. Our study provided theoretical basis for drug treatment of OP.

View Figures

View References

1	Anagnostis P, Vakalopoulou S, Christoulas D, Paschou SA, Papatheodorou A, Garipidou V, Kokkoris P and Terpos E: The role of sclerostin/dickkopf-1 and receptor activator of nuclear factor κB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study. Haemophilia. 24:316–322. 2018. View Article : Google Scholar : PubMed/NCBI
2	Armstrong DJ: Comment on: Patients' preferences for anti-osteoporosis drug treatment: A cross-European discrete choice experiment. Rheumatology (Oxford). 57:583–584. 2018. View Article : Google Scholar : PubMed/NCBI
3	Paccou J and Cortet B: Bisphosphonate drug holidays in postmenopausal osteoporosis: Effect on clinical fracture risk. Response to comments by Bredemeier. Osteoporos Int. 29:5212018. View Article : Google Scholar : PubMed/NCBI
4	Hiligsmann M, Dellaert BG, Watson V and Boonen A: Comment on: Patients' preferences for anti-osteoporosis drug treatment: A cross-European discrete choice experiment: Reply. Rheumatology (Oxford). 57:584–585. 2018. View Article : Google Scholar : PubMed/NCBI
5	Nogués X, Nolla JM, Casado E, Jódar E, Muñoz-Torres M, Quesada-Gómez JM, Canals L, Balcells M and Lizán L: Spanish consensus on treat to target for osteoporosis. Osteoporos Int. 29:489–499. 2018. View Article : Google Scholar : PubMed/NCBI
6	Cano A, Chedraui P, Goulis DG, Lopes P, Mishra G, Mueck A, Senturk LM, Simoncini T, Stevenson JC, Stute P, et al: Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide. Maturitas. 107:7–12. 2018. View Article : Google Scholar : PubMed/NCBI
7	Li NB, Sun SJ, Bai HY, Xiao GY, Xu WH, Zhao JH, Chen X, Lu YP and Zhang YL: Preparation of well-distributed titania nanopillar arrays on Ti6Al4V surface by induction heating for enhancing osteogenic differentiation of stem cells. Nanotechnology. 29:0451012018. View Article : Google Scholar : PubMed/NCBI
8	Tian Y, Cui LH, Xiang SY, Xu WX, Chen DC, Fu R, Zhou CL, Liu XQ, Wang YF and Wang XT: Osteoblast-oriented differentiation of BMSCs by co-culturing with composite scaffolds constructed using silicon-substituted calcium phosphate, autogenous fine particulate bone powder and alginate in vitro. Oncotarget. 8:88308–88319. 2017. View Article : Google Scholar : PubMed/NCBI
9	McAlinden A and Im GI: MicroRNAs in orthopaedic research: Disease associations, potential therapeutic applications, and perspectives. J Orthop Res. 36:33–51. 2018.PubMed/NCBI
10	Raghuwanshi S, Gutti U, Kandi R and Gutti RK: MicroRNA-9 promotes cell proliferation by regulating RUNX1 expression in human megakaryocyte development. Cell Prolif. 51:512018. View Article : Google Scholar
11	Wu DM, Zhang YT, Lu J and Zheng YL: Effects of microRNA-129 and its target gene c-Fos on proliferation and apoptosis of hippocampal neurons in rats with epilepsy via the MAPK signaling pathway. J Cell Physiol. 233:6632–6643. 2018. View Article : Google Scholar : PubMed/NCBI
12	Tokar T, Pastrello C, Rossos AEM, Abovsky M, Hauschild AC, Tsay M, Lu R and Jurisica I: mirDIP 4.1-integrative database of human microRNA target predictions. Nucleic Acids Res. 46(D1): D360–D370. 2018. View Article : Google Scholar : PubMed/NCBI
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
14	Qi M, Zhang L, Ma Y, Shuai Y, Li L, Luo K, Liu W and Jin Y: Autophagy maintains the function of bone marrow mesenchymal stem cells to prevent estrogen deficiency-induced osteoporosis. Theranostics. 7:4498–4516. 2017. View Article : Google Scholar : PubMed/NCBI
15	Hu Y, Tan LJ, Chen XD, Liu Z, Min SS, Zeng Q, Shen H and Deng HW: Identification of novel potentially pleiotropic variants associated with osteoporosis and obesity using the cFDR method. J Clin Endocrinol Metab. 103:125–138. 2018. View Article : Google Scholar : PubMed/NCBI
16	Collison J: Osteoporosis: Teriparatide preferable for fracture prevention. Nat Rev Rheumatol. 14:42018. View Article : Google Scholar
17	Fukushima H, Shimizu K, Watahiki A, Hoshikawa S, Kosho T, Oba D, Sakano S, Arakaki M, Yamada A, Nagashima K, et al: NOTCH2 Hajdu-Cheney mutations escape SCFFBW7-dependent proteolysis to promote osteoporosis. Mol Cell. 68(645–658): e52017.
18	Xu TB, Li L, Luo XD and Lin H: BMSCs protect against liver injury via suppressing hepatocyte apoptosis and activating TGF-β1/Bax singling pathway. Biomed Pharmacother. 96:1395–1402. 2017. View Article : Google Scholar : PubMed/NCBI
19	Chen L, Lu FB, Chen DZ, Wu JL, Hu ED, Xu LM, Zheng MH, Li H, Huang Y, Jin XY, et al: BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis. Mol Immunol. 93:38–46. 2018. View Article : Google Scholar : PubMed/NCBI
20	Wang Y, Luo S, Zhang D, Qu X and Tan Y: Sika pilose antler type I collagen promotes BMSC differentiation via the ERK1/2 and p38-MAPK signal pathways. Pharm Biol. 55:2196–2204. 2017. View Article : Google Scholar : PubMed/NCBI
21	Huang J, Meng Y, Liu Y, Chen Y, Yang H, Chen D, Shi J and Guo Y: MicroRNA-320a regulates the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting HOXA10. Cell Physiol Biochem. 38:40–48. 2016. View Article : Google Scholar : PubMed/NCBI
22	Kim YJ, Bae SW, Yu SS, Bae YC and Jung JS: miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J Bone Miner Res. 24:816–825. 2009. View Article : Google Scholar : PubMed/NCBI
23	Meng YB, Li X, Li ZY, Zhao J, Yuan XB, Ren Y, Cui ZD, Liu YD and Yang XJ: microRNA-21 promotes osteogenic differentiation of mesenchymal stem cells by the PI3K/β-catenin pathway. J Orthop Res. 33:957–964. 2015. View Article : Google Scholar : PubMed/NCBI